  |
 | Up a level |
Aapro, Matti and Karthaus, Meinolf and Schwartzberg, Lee and Bondarenko, Igor and Sarosiek, Tomasz and Oprean, Cristina and Cardona-Huerta, Servando and Hansen, Vincent and Rossi, Giorgia and Rizzi, Giada and Borroni, Maria Elisa and Rugo, Hope (2017) NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron. Supportive Care in Cancer, 25 (4). pp. 1127-1135. ISSN 0941-4355 (Print) 1433-7339 (Online)
Robertson, John F R and Bondarenko, Igor M and Trishkina, Ekaterina and Dvorkin, Mikhail and Panasci, Lawrence and Manikhas, Alexey and Shparyk, Yaroslav and Cardona-Huerta, Servando and Cheung, Kwok-Leung and Philco-Salas, Manuel Jesus and Ruiz-Borrego, Manuel and Shao, Zhimin and Noguchi, Shinzaburo and Rowbottom, Jacqui and Stuart, Mary and Grinsted, Lynda M and Fazal, Mehdi and Ellis, Matthew J (2016) Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. The Lancet, 388 (10063). pp. 2997-3005. ISSN 1474-547X
